Possible role of PAPR-1 in protecting human HaCaT cells against cytotoxicity of SiO2 nanoparticles

Toxicology Letters

Volumn 280, Issue , 2017, Pages 213-221

  Gong, Chunmei ^a   Yang, Linqing ^b   Zhou, Jichang ^a   Guo, Xiang ^c   Zhuang, Zhixiong ^b  

^a Shenzhen Center for Chronic Disease Control   (China)

^b SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c Hospital for Occupational Diseases Control of Shenzhen   (China)

Author keywords

Cell transfection; DNA damage; Nano SiO2; Poly(ADP ribose) polymerase

Indexed keywords

DNA; LACTATE DEHYDROGENASE; LENTIVIRUS VECTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 2; SILICA NANOPARTICLE; NANOPARTICLE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PARP1 PROTEIN, HUMAN; SILICON DIOXIDE;

APOPTOSIS; ARTICLE; CELL CYCLE REGULATION; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; GENE EXPRESSION; GENE SILENCING; GENOTOXICITY; HACAT CELL LINE; HUMAN; HUMAN CELL; NANOTOXICOLOGY; NUMERICAL CHROMOSOME ABERRATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; STRUCTURAL CHROMOSOME ABERRATION; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CHEMICALLY INDUCED; CHEMISTRY; CHROMOSOME ABERRATION; DRUG EFFECTS; GENE DELETION; GENETICS; METABOLISM;

CELL CYCLE; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CHROMOSOME ABERRATIONS; GENE DELETION; HUMANS; NANOPARTICLES; POLY (ADP-RIBOSE) POLYMERASE-1; SILICON DIOXIDE;

EID: 85029088501     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2017.07.213     Document Type: Article

References (36)

1. Al, W.R., El-Rabih, W., Katerji, M., Safi, R., El, S.M., El-Rifai, O., Usta, J., Chemosensitivity of MCF-7 cells to eugenol: release of cytochrome-c and lactate dehydrogenase. Sci. Rep., 7, 2017, 43730.
2. Ame, J.C., Rolli, V., Schreiber, V., Niedergang, C., Apiou, F., Decker, P., Muller, S., Hoger, T., Menissier-de, M.J., de Murcia, G., PARP-2, A novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase. J. Biol. Chem. 274 (1999), 17860–17868.
3. Caiafa, P., Guastafierro, T., Zampieri, M., Epigenetics: poly(ADP-ribosyl)ation of PARP-1 regulates genomic methylation patterns. FASEB J. 23 (2009), 672–678.
4. Chatterjee, S., Berger, S.J., Berger, N.A., Poly(ADP-ribose) polymerase: a guardian of the genome that facilitates DNA repair by protecting against DNA recombination. Mol. Cell. Biochem. 193 (1999), 23–30.
5. Chen, M., von Mikecz, A., Formation of nucleoplasmic protein aggregates impairs nuclear function in response to SiO2 nanoparticles. Exp. Cell Res. 305 (2005), 51–62.
6. Curtin, N.J., Szabo, C., Therapeutic applications of PARP inhibitors: anticancer therapy and beyond. Mol. Asp. Med. 34 (2013), 1217–1256.
7. El-Ansary, A., Al-Daihan, S., On the toxicity of therapeutically used nanoparticles: an overview. J. Toxicol., 2009, 2009.
8. Eros, K., Magyar, K., Deres, L., Skazel, A., Riba, A., Vamos, Z., Kalai, T., Gallyas, F.J., Sumegi, B., Toth, K., Halmosi, R., Chronic PARP-1 inhibition reduces carotid vessel remodeling and oxidative damage of the dorsal hippocampus in spontaneously hypertensive rats. PLoS One, 12, 2017, e174401.
9. Felici, R., Cavone, L., Lapucci, A., Guasti, D., Bani, D., Chiarugi, A., PARP inhibition delays progression of mitochondrial encephalopathy in mice. Neurotherapeutics 11 (2014), 651–664.
10. Fenech, M., Chang, W.P., Kirsch-Volders, M., Holland, N., Bonassi, S., Zeiger, E., HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures. Mutat. Res. 534 (2003), 65–75.
11. Gao, A., Song, S., Wang, D., Peng, W., Tian, L., Effect of silicon dioxide on expression of poly (ADP-ribose) polymerase mRNA and protein. Cell Biol. Int. 33 (2009), 749–754.
12. Gibson, B.A., Kraus, W.L., New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs. Nat. Rev. Mol. Cell Biol. 13 (2012), 411–424.
13. Gong, C., Tao, G., Yang, L., Liu, J., He, H., Zhuang, Z., The role of reactive oxygen species in silicon dioxide nanoparticle-induced cytotoxicity and DNA damage in HaCaT cells. Mol. Biol. Rep. 39 (2012), 4915–4925.
14. Gorczyca, W., Gong, J., Darzynkiewicz, Z., Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res. 53 (1993), 1945–1951.
15. Hahn, W.C., Dessain, S.K., Brooks, M.W., King, J.E., Elenbaas, B., Sabatini, D.M., DeCaprio, J.A., Weinberg, R.A., Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol. Cell Biol. 22 (2002), 2111–2123.
16. Hemberger, M., Nozaki, T., Winterhager, E., Yamamoto, H., Nakagama, H., Kamada, N., Suzuki, H., Ohta, T., Ohki, M., Masutani, M., Cross, J.C., Parp1-deficiency induces differentiation of ES cells into trophoblast derivatives. Dev. Biol. 257 (2003), 371–381.
17. Johansson, M., A human poly(ADP-ribose) polymerase gene family (ADPRTL): cDNA cloning of two novel poly(ADP-ribose) polymerase homologues. Genomics 57 (1999), 442–445.
18. Kim, M.Y., Mauro, S., Gevry, N., Lis, J.T., Kraus, W.L., NAD+-dependent modulation of chromatin structure and transcription by nucleosome binding properties of PARP-1. Cell 19 (2004), 803–814.
19. Kraus, W.L., Hottiger, M.O., PARP-1 and gene regulation: progress and puzzles. Mol. Asp. Med. 34 (2013), 1109–1123.
20. Li, S., Cui, Z., Meng, X., Knockdown of PARP-1 inhibits proliferation and ERK signals, increasing drug sensitivity in osteosarcoma U2OS cells. Oncol. Res. 24 (2016), 279–286.
21. Magyar, K., Deres, L., Eros, K., Bruszt, K., Seress, L., Hamar, J., Hideg, K., Balogh, A., Gallyas, F.J., Sumegi, B., Toth, K., Halmosi, R., A quinazoline-derivative compound with PARP inhibitory effect suppresses hypertension-induced vascular alterations in spontaneously hypertensive rats. Biochim. Biophys. Acta 1842 (2014), 935–944.
22. Napierska, D., Thomassen, L.C., Rabolli, V., Lison, D., Gonzalez, L., Kirsch-Volders, M., Martens, J.A., Hoet, P.H., Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. Small 5 (2009), 846–853.
23. Nozaki, T., Fujimori, H., Wang, J., Suzuki, H., Imai, H., Watanabe, M., Ohura, K., Masutani, M., Parp-1 deficiency in ES cells promotes invasive and metastatic lesions accompanying induction of trophoblast giant cells during tumorigenesis in uterine environment. Pathol. Int. 63 (2013), 408–414.
24. Ogata, S., Okumura, K., Taguchi, H., A simple and rapid method for the detection of poly(ADP-ribose) by flow cytometry. Biosci. Biotechnol. Biochem. 64 (2000), 510–515.
25. Park, S.H., Jang, K.Y., Kim, M.J., Yoon, S., Jo, Y., Kwon, S.M., Kim, K.M., Kwon, K.S., Kim, C.Y., Woo, H.G., Tumor suppressive effect of PARP1 and FOXO3A in gastric cancers and its clinical implications. Oncotarget 6 (2015), 44819–44831.
26. Passeri, D., Camaioni, E., Liscio, P., Sabbatini, P., Ferri, M., Carotti, A., Giacche, N., Pellicciari, R., Gioiello, A., Macchiarulo, A., Concepts and molecular aspects in the polypharmacology of PARP-1 inhibitors. ChemMedChem 11 (2016), 1219–1226.
27. Pirinen, E., Canto, C., Jo, Y.S., Morato, L., Zhang, H., Menzies, K.J., Williams, E.G., Mouchiroud, L., Moullan, N., Hagberg, C., Li, W., Timmers, S., Imhof, R., Verbeek, J., Pujol, A., van Loon, B., Viscomi, C., Zeviani, M., Schrauwen, P., Sauve, A.A., Schoonjans, K., Auwerx, J., Pharmacological Inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle. Cell Metab. 19 (2014), 1034–1041.
28. Schreiber, V., Dantzer, F., Ame, J.C., de Murcia, G., Poly(ADP-ribose): novel functions for an old molecule. Nat. Rev. Mol. Cell Biol. 7 (2006), 517–528.
29. Shieh, W.M., Ame, J.C., Wilson, M.V., Wang, Z.Q., Koh, D.W., Jacobson, M.K., Jacobson, E.L., Poly(ADP-ribose) polymerase null mouse cells synthesize ADP-ribose polymers. J. Biol. Chem. 273 (1998), 30069–30072.
30. Tao, G.H., Yang, L.Q., Gong, C.M., Huang, H.Y., Liu, J.D., Liu, J.J., Yuan, J.H., Chen, W., Zhuang, Z.X., Effect of PARP-1 deficiency on DNA damage and repair in human bronchial epithelial cells exposed to Benzo(a)pyrene. Mol. Biol. Rep. 36 (2009), 2413–2422.
31. Wacker, D.A., Ruhl, D.D., Balagamwala, E.H., Hope, K.M., Zhang, T., Kraus, W.L., The DNA binding and catalytic domains of poly(ADP-ribose) polymerase 1 cooperate in the regulation of chromatin structure and transcription. Mol. Cell. Biol. 27 (2007), 7475–7485.
32. Xu, B., Kim, S., Kastan, M.B., Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation. Mol. Cell. Biol. 21 (2001), 3445–3450.
33. Yang, H., Liu, C., Yang, D., Zhang, H., Xi, Z., Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition. J. Appl. Toxicol. 29 (2009), 69–78.
34. Yang, X., Liu, J., He, H., Zhou, L., Gong, C., Wang, X., Yang, L., Yuan, J., Huang, H., He, L., Zhang, B., Zhuang, Z., SiO2 nanoparticles induce cytotoxicity and protein expression alteration in HaCaT cells. Part. Fibre Toxicol., 7, 2010, 1.
35. Yuan, K., Sun, Y., Zhou, T., McDonald, J., Chen, Y., PARP-1 regulates resistance of pancreatic cancer to TRAIL therapy. Clin. Cancer Res. 19 (2013), 4750–4759.
36. Zheng, Y.D., Xu, X.Q., Peng, F., Yu, J.Z., Wu, H., The poly(ADP-ribose) polymerase-1 inhibitor 3-aminobenzamide suppresses cell growth and migration, enhancing suppressive effects of cisplatin in osteosarcoma cells. Oncol. Rep. 25 (2011), 1399–1405.